Advertisement Oragenics signs agreement with Garden of Life for probiotic ingredient - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Oragenics signs agreement with Garden of Life for probiotic ingredient

Oragenics, a biotechnology company, has licensed the use of its oral-care probiotic ingredient, ProBiora3 to Garden of Life, a provider of dietary supplements and probiotics.

This agreement gives Garden of Life exclusive rights to use ProBiora3 in the natural products market. ProBiora3 is a patent-pending probiotic formula containing a blend of three bacteria that work below the gum line to address oral health at its root cause.

According to Oragenics, the ProBiora3 is a 100% natural ingredient that helps to re-establish a healthy balance of oral microflora. It is the first complete oral care probiotic blend that supports tooth and gum health, naturally freshens breath and gently whitens teeth.

Stanley Stein, CEO and president of Oragenics, said: “Garden of Life is a leading innovator in the natural products industry. We selected this formidable company for this exclusive relationship because we share a similar vision.

“Like Garden of Life, Oragenics is passionate about helping people transform their lives and attain extraordinary health through natural, biotechnological solutions. This is a terrific opportunity to have an enormous impact on oral health and wellness worldwide.”